These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25249434)

  • 61. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
    Silber J; Lim DA; Petritsch C; Persson AI; Maunakea AK; Yu M; Vandenberg SR; Ginzinger DG; James CD; Costello JF; Bergers G; Weiss WA; Alvarez-Buylla A; Hodgson JG
    BMC Med; 2008 Jun; 6():14. PubMed ID: 18577219
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes.
    Jenkinson MD; Smith TS; Joyce K; Fildes D; du Plessis DG; Warnke PC; Walker C
    Neurology; 2005 Jun; 64(12):2085-9. PubMed ID: 15985578
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.
    Ivliev AE; 't Hoen PA; Sergeeva MG
    Cancer Res; 2010 Dec; 70(24):10060-70. PubMed ID: 21159630
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pathology and molecular genetics of oligodendroglial tumors.
    Hartmann C; Mueller W; von Deimling A
    J Mol Med (Berl); 2004 Oct; 82(10):638-55. PubMed ID: 15322700
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression.
    Asslaber M; Schauer S; Gogg-Kamerer M; Bernhart E; Quehenberger F; Haybaeck J
    J Neuropathol Exp Neurol; 2017 Jan; 76(1):16-26. PubMed ID: 28040794
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Absence of 1p/19q codeletion in oligodendroglioma-like areas of pilocytic astrocytomas.
    Frazer B; Kearney H; Cryan J; Beausang A; Brett F; Farrell MA; Buckley PG
    Clin Neuropathol; 2018; 37(4):182-185. PubMed ID: 29595124
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The definition of primary and secondary glioblastoma.
    Ohgaki H; Kleihues P
    Clin Cancer Res; 2013 Feb; 19(4):764-72. PubMed ID: 23209033
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [THE STUDY OF THE ORIGIN OF HUMAN GLIOMA BASED ON CELL LINES AND TUMOR SPECIMENS].
    Timin GV; Lakhina YS; Gulyaev DA; Tolkunova EN
    Tsitologiia; 2015; 57(12):893-8. PubMed ID: 26995968
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.
    Rickman DS; Bobek MP; Misek DE; Kuick R; Blaivas M; Kurnit DM; Taylor J; Hanash SM
    Cancer Res; 2001 Sep; 61(18):6885-91. PubMed ID: 11559565
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Anaplastic glioma. Neuropathology, molecular diagnostics and current study concepts].
    Wick W; Weller M
    Nervenarzt; 2010 Aug; 81(8):928-30, 932-5. PubMed ID: 20635074
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma.
    Ritland SR; Ganju V; Jenkins RB
    Genes Chromosomes Cancer; 1995 Apr; 12(4):277-82. PubMed ID: 7539282
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Molecular cytogenetic analysis of chromosomal aberrations in cells of low grade gliomas and its contribution for tumour classification].
    Lhotská H; Zemanová Z; Kramář F; Lizcová L; Svobodová K; Ransdorfová S; Bystřická D; Krejčík Z; Hrabal P; Dohnalová A; Kaiser M; Michalová K
    Klin Onkol; 2014; 27(3):183-91. PubMed ID: 24918277
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Flow cytometric analysis of cellular DNA content in human astrocytomas and oligodendrogliomas.
    Ahyai A
    Neurosurg Rev; 1988; 11(2):177-87. PubMed ID: 3244416
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.
    Gelpi E; Ambros IM; Birner P; Luegmayr A; Drlicek M; Fischer I; Kleinert R; Maier H; Huemer M; Gatterbauer B; Anton J; Rössler K; Budka H; Ambros PF; Hainfellner JA
    Mod Pathol; 2003 Jul; 16(7):708-15. PubMed ID: 12861068
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pathology of low- and intermediate-grade gliomas.
    Fuller CE; Perry A
    Semin Radiat Oncol; 2001 Apr; 11(2):95-102. PubMed ID: 11285547
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas.
    Cooper LA; Gutman DA; Long Q; Johnson BA; Cholleti SR; Kurc T; Saltz JH; Brat DJ; Moreno CS
    PLoS One; 2010 Sep; 5(9):e12548. PubMed ID: 20838435
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative transcriptomics reveals similarities and differences between astrocytoma grades.
    Seifert M; Garbe M; Friedrich B; Mittelbronn M; Klink B
    BMC Cancer; 2015 Dec; 15():952. PubMed ID: 26673168
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular pathology of oligodendroglial tumors.
    Hartmann C; von Deimling A
    Recent Results Cancer Res; 2009; 171():25-49. PubMed ID: 19322536
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
    Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
    Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.